Correlation Between Merck and Innovator Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Innovator Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Innovator Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Innovator Equity Accelerated, you can compare the effects of market volatilities on Merck and Innovator Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Innovator Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Innovator Equity.

Diversification Opportunities for Merck and Innovator Equity

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Merck and Innovator is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Innovator Equity Accelerated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Equity Acc and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Innovator Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Equity Acc has no effect on the direction of Merck i.e., Merck and Innovator Equity go up and down completely randomly.

Pair Corralation between Merck and Innovator Equity

Considering the 90-day investment horizon Merck Company is expected to under-perform the Innovator Equity. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.41 times less risky than Innovator Equity. The stock trades about -0.31 of its potential returns per unit of risk. The Innovator Equity Accelerated is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  3,315  in Innovator Equity Accelerated on January 13, 2025 and sell it today you would lose (158.00) from holding Innovator Equity Accelerated or give up 4.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Innovator Equity Accelerated

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Innovator Equity Acc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Innovator Equity Accelerated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking indicators, Innovator Equity is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Merck and Innovator Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Innovator Equity

The main advantage of trading using opposite Merck and Innovator Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Innovator Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Equity will offset losses from the drop in Innovator Equity's long position.
The idea behind Merck Company and Innovator Equity Accelerated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon